Use of exercise for treatment of chronic fatigue syndrome

Sports Medicine

Volumn 21, Issue 1, 1996, Pages 35-48

  McCully, Kevin K ^a   Sisto, Sue Ann ^b,c   Natelson, Benjamin H ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c KESSLER INSTITUTE FOR REHABILITATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN; INTERLEUKIN 2; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AEROBIC METABOLISM; CHRONIC FATIGUE SYNDROME; DIET THERAPY; EXERCISE; HISTOLOGY; HUMAN; IMMUNOPATHOLOGY; IMMUNOTHERAPY; KINESIOTHERAPY; MITOCHONDRIAL RESPIRATION; MUSCLE BLOOD FLOW; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE METABOLISM; MUSCLE STRENGTH; MUSCLE WEAKNESS; PATHOLOGY; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PREVALENCE; PSYCHOTHERAPY; RELAPSE; REST; REVIEW; SYMPTOM; VIRUS INFECTION;

EID: 0030042899     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-199621010-00004     Document Type: Review

References (78)

1. Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991; 13 Suppl. 1: S8-11
2. Shorter E. Chronic fatigue in historical perspective. In Chronic fatigue syndrome. Ciba Foundation symposium no. 173 Chichester: Wiley and Sons, 1993: 6-22
3. Wessely S. History of postviral fatigue syndrome. Br Med Bul 1991; 47: 919-41
4. Wolfe F, Smythe HA, Aeons MB. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160-72
5. Holmes GP, Kaplan JE, Schonberger LB, et al. Definition of the chronic fatigue syndrome [letter]. Ann Intern Med 1988; 109: 512
6. Schluederberg A, Straus SE, Peterson P, et al. Chronic fatigue syndrome research: definition and medical outcome assessment. Ann Intern Med 1992; 117: 325-31
7. Fukuda K, Straus SE, Hickie I, et al. Chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-8
8. Blondel-Hill E, Shafran SD. Treatment of the chronic fatigue syndrome: a review and practical guide. Drugs 1993; 46: 639-51
9. Lloyd AR, Hickie I, Boughton CR, et al. Prevalence of chronic-fatigue syndrome in an Australian population. Med J Aust 1990a; 153: 522-8
10. Natelson BH, Ye N, Moul DE, et al. High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness. J Med Virol 1994; 42: 42-6
11. Edwards RHT, Gibson H, Clague JE, et al. Muscle histopathology and physiology in chronic fatigue syndrome. In: Bock GR, Whalan J, editors. Chronic fatigue syndrome. Ciba Foundation symposium no. 173. Chichester: John Wiley and Sons, 1993: 102-31
12. Kuratsune H, Yamaguti K, Takahashi M, et al. Acetylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl. 1: S62-7
13. Bates DW, Buchwald D, Lee J, et al. A comparison of case definitions of chronic fatigue syndrome. Clin Infect Dis 1994; 18 1: S11-5
14. Bates DW, Schmitt W, Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993; 153: 2759-65
15. Klimas N, Salvalo F, Morgan R, et al. Immunological abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403-10
16. Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active herpes virus type 6 infection. Ann Intern Med 1992; 116: 103-13
17. Keller RH, Lane JL, Klimas N, et al. Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome. Clin Infect Dis 1994; 18 Suppl. 1: S154-6
18. Straus SE, Fritz S, Dale JK, et al. Lymphocyte phenotype and function in the chronic fatigue syndrome. J Clin Immunol 1993; 13: 30-40
19. Barker E, Fujimura SF, Fadem MB, et al. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl. 1: S136-41
20. Wessely S, Chalder T, Hirsch S, et al. Postinfection fatigue: prospective cohort study in primary care. Lancet 1995; 345: 1333-8
21. Abbey SE, Garfinkel PE. Chronic fatigue syndrome and depression: cause, effect, or covariate. Rev Infect Dis 1991; 13 Suppl. 1: S73-83
22. Thase ME. Assessment of depression in patients with chronic fatigue syndrome. Rev Infect Dis 1991; 13 Suppl. 1: S114-8
23. Grafman J, Johnson R, Scheffers M. Cognitive and mood-state changes in patients with chronic fatigue syndrome. Rev Infect Dis 1991; 13 Suppl. 1: S45-50
24. Surawy C, Hackmann A, Hawton K, et al. Chronic fatigue syndrome: a cognitive approach. Behav Res Ther 1995; 33: 535-44
25. Petrie K, Moss-Morris R, Weinman J. The impact of catastrophic beliefs on functioning in chronic fatigue syndrome. J Psychosom Res 1995: 39; 31-7
26. Calabrese L, Davis ME, Wilke W. Chronic fatigue syndrome and a disorder resembling Sjogren's syndrome: preliminary report. Clin Infect Dis 1994; 18 Suppl. 1: S28-31
27. Komaroff AL. Clinic presentation of chronic fatigue syndrome. In: Bock GR, Whalan J, editors. Chronic fatigue syndrome. Ciba Foundation symposium no. 173. Chichester: John Wiley & Sons, 1993: 43-61
28. Noakes TD. Implications of exercise testing for prediction of athletic performance: a contemporary perspective. Med Sci Sports Exerc 1988; 20: 319-30
29. 2max - new concepts on an old theme. Med Sci Sports Exerc 1992; 24: 26-9
30. Wagner PD. Gas exchange and peripheral diffusion limitation. Med Sci Sports Exerc 1992; 24: 54-8
31. Kent-Braun J, Sharma KR, Weiner MW, et al. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 1993; 43: 125-31
32. Riley MS, O'Brien CJ, McCluskey DR, et al. Aerobic work capacity in patients with chronic fatigue syndrome. BMJ 1990; 301: 953-6
33. Gibson H, Carroll N, Clague JE, et al. Exercise performance and faligability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1993; 56: 993-8
34. Stokes MJ, Cooper RG, Edwards RHT. Normal muscle strength and fatigability in patient with effort syndromes. BMJ 1988; 297: 1014-7
35. Montague TJ, Marrie TJ, Bewick DJ, et al. Cardiac effects of common viral illnesses. Chest 1988; 94: 919-25
36. Skinner JS, Baldini FD, Gardner AW. Assessment of fitness. In: Bouchard C, Shepard RJ, Stephens T, et al., editors. Exercise, fitness, and health. Champaign (IL): Human Kinetics Publishers, 1990: 109-20
37. Lloyd AR, Phales J, Gandevia SC. Muscle strength, endurance and recovery in the post-infection fatigue syndrome. J Neurol Neurosurg Psychiatry 1988; 51: 1316-22
38. Lindh M, Johansson G, Hedberg M, et al. Studies on maximal voluntary contraction in patients with fibromyalgia. Arch Phys Med Rehab 1994; 75: 1217-22
39. 31P nuclear magnetic resonance spectroscopy. Chest 1992; 102: 1716-22
40. Evans WJ, Phinney SD, Young VR. Suction applied to a muscle biopsy maximises sample size. Med Sci Sports Exerc 1982; 14: 101-2
41. Chance B, Eleff S, Leigh Jr JS, et al. Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31-P NMR study. Proc Natl Acad Sci USA 1981; 78: 6714-8
42. Barnes PRJ, Taylor DJ, Kemp GJ, et al. Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1993; 56: 679-83
43. McCully KK, Vandenborne K, Posner JD. Magnetic resonance in physiology and medicine. In: Gillies R, editor. NMR in physiology and medicine. San Diego: Academic Press, Inc., 1994
44. Behan WMH, More IAR, Behun PO. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol 1991; 83: 61-5
45. Byrne E, Trounce I, Dennett X. Chronic relapsing myalgia (? post viral): clinical histological and biochemical studies. Aust NZJ Med 1985; 15: 305-8
46. Byrne E, Trounce I. Chronic fatigue and myalgia syndrome: mitochondrial and glycolytic studies in skeletal muscle. J Neurol Neurosurg Psychiatry 1987; 50: 743-6
47. Arnold DL, Radda GK, Bore PJ, et al. Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. Lancet 1984; i: 1367-9
48. McCully K, Natelson B, Sisto S-A, et al. Impaired phosphocrealine recovery in women with chronic fatigue syndrome. Med Sci Sports Exerc 1993; 25 Suppl.: S16
49. Bennett RM. Muscle physiology and cold reactivity in the fibromyalgia syndrome. Rheum Dis Clin North Am 1989; 15: 135-47
50. Lindh M, Johansson G, Hedherg M, et al. Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol 1995; 24: 34-7
51. Bennett RM, Clark SR, Campbell SM, et al. Symptoms of Raynaud's syndrome in patienls with fibromyalgia. Arthritis Rheum 1991; 34: 264-9
52. Convertino V. Exercise and adaptation to microgravity environments. In: Fregly J, Blatteis C, editors. Handbook of physiology: adaptation to the environment. Bethesda (MD): American Physiological Society. In press
53. McCully KK, Kakihira H, Vandenborne K, et al. Noninvasive measurements of activity-induced changes in muscle metabolism. J Biomech 1991; 24 Suppl.: 153-62
54. Kent-Braun J, Sharma KR, Miller RG, et al. Postexercise phosphocreatine resynthesis is slowed in multiple sclerosis. Muscle Nerve 1994; 17: 835-41
55. Vermkos J, Ludwig D. Intermittent gravity: how much, how often, and how long? Tech Memo no. 108800. Moffett Field (CA): NASA Ames Research Center, 1993
56. Behan PO, Behan WMH, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990; 82: 209-16
57. Jubrias SA, Bennett RM, Klug GA. Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyaglia patients. Athritis Rheum 1994; 37: 801-7
58. Armstrong RB. Mechanisms of exercise-induced delayed onset muscular soreness: a brief review. Med Sci Sport Exerc 1984; 16: 529-38
59. Sisto SA. Chronic fatigue syndrome: an overview and intervention guidelines. Neurol Rep 1993; 17: 30-4
60. Lloyd AR, Gandevia S, Brockman A, et al. Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. Clin Infect Dis 1994; 18 Suppl. 1: S142-6
61. Newsholme EA, Parry-Billings M. Effects of exercise on the immune system. In: Bouchard C, Shepard RJ, Stephens T, editors. Physical activity, fitness, and health. Champaign (IL): Human Kinetics Publishers, 1994: 451-5
62. Gantz NM, Holmes GP Treatment of patients with chronic fatigue syndrome. Drugs 1989; 38: 855-62
63. Sharpe MC. Follow-up of patients presenting with fatigue to an infectious disease clinic. BMJ 1992; 305: 147-52
64. Goldman JA. Hypermobilty and deconditioning: important links to fibromyalgia/fibrositis. South Med J 1991; 84: 1192
65. McCain CA, Bell DA, Mai FM, et al. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum 1988; 31: 1135
66. Straus SE, Dale JK, Tobi M, et al. Acyclovir treatment of the chronic fatigue syndrome: lack of efficacy in a placebo-controlled trial. N Engl J Med 1988; 26: 1692-8
67. Lloyd AR, Hickie I, Wakefield D, et al. Placebo-control led trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. BMJ 1990b; 89: 561-8
68. Lloyd AR, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double blind, placebo-controlled trial. Am J Med 1993; 94: 197-203
69. Peterson PK, Shepurd J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990; 89: 554-60
70. Cox IM, Campbell MJ, Dawson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991; 337: 557
71. Kaslow JE, Rucker L, Onishi R. Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. Arch Intern Med 1989; 149: 2501-3
72. Kuragaki H, Yamaguchi K, Kitani T. Decrease in serum carnitine level of patients with chronic fatigue syndrome [summary report]. 2nd Meeting of the research committee on surveillance study of current CFS situations in japan and pathogenesis and clinical features of CFS: 1993 Mar 8; Tokyo, Japan. 1-7
73. Morris DH, Stark FJ. Unproven diet therapies in the treatment of the chronic fatigue syndrome. Arch Fain Med 1993; 2: 181-6
74. Wilson A, Hickie I, Lloyd A, et al. Longitudinal study of outcome of chronic fatigue syndrome. BMJ 1994; 308: 756-9
75. Kroenke K, Wood DO, Mangelsdorff AD. Chronic fatigue in primary care: prevalence, patient characteristics, and outcome. JAMA 1988; 260: 929-34
76. Clark MR, Katon W, Russo J, et al. Chronic fatigue: risk factors for symptom persistance in a 21/2: year follow-up study. Am J Med 1995; 98: 187-95
77. Hyde B, Bergmann S. Akureyri disease (myalgic encephalomyelitis), forty years later [letter]. Lancet 1988 Nov: 19: 1190-1
78. Deluca J, Johnson SK, Beldowicz D, et al. Neuropsychologic impairments in chronic fatigue syndrome, multiple sclerosis, and depression. J Neurol Neurosurg Psychiatry 1995; 58: 38-43